Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-11-08 00:00:00 ET · period of report 2022-11-04 · accession 0001883850-22-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-08 | 2022-11-07 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $745.40 | -7,886 | 31.0K | -20% | -$5.88M |
| D | 2022-11-08 | 2022-11-04 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $381.92 | +34.0K | 64.6K | +111% | +$12.99M |
| D | 2022-11-08 | 2022-11-04 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $725.84 | -26.1K | 38.5K | -40% | -$18.95M |
| D | 2022-11-08 | 2022-11-04 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $0.00 | -34.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-07 | S | D | 1,100 | $743.39 | 37,264 | D | — | — | (F1) Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 7, 2022 at prices ranging from $743.00 to $743.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-11-07 | S | D | 404 | $747.20 | 30,578 | D | — | — | (F5) Represents volume-weighted average price of sales of 404 shares of Company stock on November 7, 2022 at prices ranging from $747.00 to $747.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-11-04 | M | A | 34,000 | $381.92 | 64,578 | D | — | — | |
| 4 | Common | Common Stock | 2022-11-04 | F | D | 26,114 | $725.84 | 38,464 | D | — | — | |
| 5 | Common | Common Stock | 2022-11-07 | S | D | 100 | $742.79 | 38,364 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-07 | S | D | 2,032 | $744.61 | 35,232 | D | — | — | (F2) Represents volume-weighted average price of sales of 2,032 shares of Company stock on November 7, 2022 at prices ranging from $744.02 to $744.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-11-07 | S | D | 1,468 | $745.51 | 33,764 | D | — | — | (F3) Represents volume-weighted average price of sales of 1,468 shares of Company stock on November 7, 2022 at prices ranging from $745.00 to $745.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-11-07 | S | D | 2,782 | $746.56 | 30,982 | D | — | — | (F4) Represents volume-weighted average price of sales of 2,782 shares of Company stock on November 7, 2022 at prices ranging from $746.15 to $746.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-11-04 | M | D | 34,000 | $0.00 | 0 | D | $381.92 · — to 2026-12-16 | 34,000 Common Stock | (F6) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |